Comparison of systemic VEGF protein dynamics following monthly intravitreal injections of 0.5 mg ranibizumab versus 2 mg aflibercept in patients with visual impairment due to diabetic macular edema

Update Il y a 4 ans
Reference: EUCTR2014-001639-35

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare systemic VEGF-A protein levels following monthly intravitreal injections of 0.5 mg ranibizumab versus 2 mg aflibercept as measured by the area under the curve (AUC) from baseline to study week 12.


Inclusion criteria

  • Visual impairment due to diabetic macula edema

Links